Consensus statement on iron overload in myelodysplastic syndromes

被引：144

作者：

Bennett, John M. ^{[1
]}

机构：

[1] Myelodysplast Syndromes Fdn, Crosswicks, NJ USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2008年 / 83卷 / 11期

关键词：

D O I：

10.1002/ajh.21269

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In May 2005 at the 8th International Symposium on Myelodysplastic Syndromes (MDS), a consensus meeting was held on iron overload in MDS (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25). The recommendations of the 2005 consensus meeting were discussed in the context of currently available evidence at the 9th International Symposium on Myelodysplastic Syndromes in Florence Italy, May 2007. The recommendations of the consensus working group are presented here. The recommendations are a continued refinement of the outcome of the 2005 consensus meeting and the ground-breaking work of others in this area (Seymour, Hematol Oncol Clin 2005; Suppl 1:18-25; Gattermann, Int J Hematol 2008;88:24-29; Alessandrino et al., Haematologica 2002;87:1286-1306; NCCN practice guidelines: Myelodysplastic Syndromes, version 2.2008). Am. J. Hematol. 83:858-861, 2008. (C) 2008 Wiley-Liss, Inc.

引用

收藏

页码：858 / 861

页数：4

相关论文

共 15 条

[1]

Alessandrino EP, 2002, HAEMATOLOGICA, V87, P1286

[2] Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation [J].

Armand, Philippe ;

Kim, Haesook T. ;

Cutler, Corey S. ;

Ho, Vincent T. ;

Koreth, John ;

Alyea, Edwin P. ;

Soiffer, Robert J. ;

Antin, Joseph H. .

BLOOD, 2007, 109 (10) :4586-4588

[3]

BOWEN DT, 2002, MYELODYSPLASTIC SYND, pCH13

[4] Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts [J].

Chee, Cheng E. ;

Steensma, David P. ;

Wu, Wenting ;

Hanson, Curtis A. ;

Tefferi, Ayalew .

AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (08) :611-613

[5]

DITUCCI AA, HAEMATOLOGI IN PRESS, DOI DOI 10.3324/HEMAT0L.12759

[6] Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload [J].

Gattermann, Norbert .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (01) :24-29

[7] Marrow transplantation for patients with thalassemia: Results in class 3 patients [J].

Lucarelli, G ;

Clift, RA ;

Galimberti, M ;

Polchi, P ;

Angelucci, E ;

Baronciani, D ;

Giardini, C ;

Andreani, M ;

Manna, M ;

Nesci, S ;

Agostinelli, F ;

Rapa, S ;

Ripalti, M ;

Albertini, F .

BLOOD, 1996, 87 (05) :2082-2088

[8] Iron overload in hematopoietic cell transplantation [J].

Majhail, N. S. ;

Lazarus, H. M. ;

Burns, L. J. .

BONE MARROW TRANSPLANTATION, 2008, 41 (12) :997-1003

[9] Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making [J].

Malcovati, L ;

Della Porta, MG ;

Pascutto, C ;

Invernizzi, R ;

Boni, M ;

Travaglino, E ;

Passamonti, F ;

Arcaini, L ;

Maffioli, M ;

Bernasconi, P ;

Lazzarino, M ;

Cazzola, M .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7594-7603

[10] Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes [J].

Malcovati, Luca ;

Germing, Ulrich ;

Kuendgen, Andrea ;

Della Porta, Matteo G. ;

Pascutto, Cristiana ;

Invernizzi, Rosangela ;

Giagounidis, Aristoteles ;

Hildebrandt, Barbara ;

Bernasconi, Paolo ;

Knipp, Sabine ;

Strupp, Corinna ;

Lazzarino, Mario ;

Aul, Carlo ;

Cazzola, Mario .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) :3503-3510